In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Negative formulations no longer allowed on packaging of medicinal products for human use

Negative formulations no longer allowed on packaging of medicinal products for human use

by In2Pharma | Jun 28, 2023 | News

Belgium Since 2019, negative formulations are no longer allowed on the packaging of medicinal products for human use in Belgium. This decision came after consultation at European level and in agreement with the other European Member States. The FAMHP will therefore...

The Dutch authorities will compensate companies for additional costs due to the Falsified Medicines Directive

by In2Pharma | Dec 5, 2018 | News

The Netherlands As a result of the Falsified Medicines Directive, companies are obliged to adapt the packaging of their medicines which leads to additional costs. These additional costs cannot always be compensated by a price increase, due to the Drug Price Act (Wet...

Recent Posts

  • Webinar Full FMD implementation
  • Food Supplements
  • Code of conduct GMH and CGR tightens the rules  
  • Introduction to FAMHP portal – manufacturing inspections
  • RD export 19/01/2023 – mandatory application for export

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België